ATP downregulates P2X7 and inhibits osteoclast formation in RAW cells

American Journal of Physiology - Cell Physiology

Volumn 287, Issue 2 56-2, 2004, Pages

  Hiken, Jeffrey F ^a   Steinberg, Thomas H ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Macrophage fusion; P2X receptor; Purinergic receptor; Receptor activator nuclear factor B

Indexed keywords

ACID PHOSPHATASE; ADENOSINE TRIPHOSPHATE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PURINE P2X7 RECEPTOR; ADENOSINE DIPHOSPHATE; ADENOSINE PHOSPHATE; ANTITHROMBOCYTIC AGENT; CARRIER PROTEIN; DRUG DERIVATIVE; MEMBRANE PROTEIN; OSTEOCLAST DIFFERENTIATION FACTOR; PURINE P2 RECEPTOR; PYRIDOXAL 5 PHOSPHATE; PYRIDOXAL PHOSPHATE 6 AZOPHENYL 2',4' DISULFONIC ACID; PYRIDOXAL PHOSPHATE-6-AZOPHENYL-2',4'-DISULFONIC ACID; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR KAPPA B; TNFRSF11A PROTEIN, MOUSE; TNFSF11 PROTEIN, MOUSE;

ANIMAL CELL; ARTICLE; CELL DEATH; CELL FUSION; CELL MEMBRANE; CONTROLLED STUDY; CYTOLYSIS; DOWN REGULATION; EMBRYO; GIANT CELL; HUMAN; HUMAN CELL; MACROPHAGE; MARKER GENE; MOUSE; NONHUMAN; OSTEOCLAST; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; RAT; SIGNAL TRANSDUCTION; STEM CELL; UPREGULATION; ANIMAL; CELL DIFFERENTIATION; CELL LINE; CYTOLOGY; DRUG EFFECT; EXTRACELLULAR SPACE; FLUORESCENT ANTIBODY TECHNIQUE; METABOLISM; PHYSIOLOGY;

ANIMALIA;

ADENOSINE DIPHOSPHATE; ADENOSINE MONOPHOSPHATE; ADENOSINE TRIPHOSPHATE; ANIMALS; CARRIER PROTEINS; CELL DIFFERENTIATION; CELL LINE; EXTRACELLULAR SPACE; FLUORESCENT ANTIBODY TECHNIQUE; GIANT CELLS; MACROPHAGES; MEMBRANE GLYCOPROTEINS; MICE; NF-KAPPA B; OSTEOCLASTS; PLATELET AGGREGATION INHIBITORS; PYRIDOXAL PHOSPHATE; RANK LIGAND; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR-KAPPA B; RECEPTORS, PURINERGIC P2; UP-REGULATION;

EID: 3242702380     PISSN: 03636143     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpcell.00361.2003     Document Type: Article

References (31)

1. 7 receptor. J Immunol 169: 4108-4112, 2002.
2. Anderson JM. Multinucleated giant cells. Curr Opin Hematol 7: 40-47, 2000.
3. Chessell IP, Simon J, Hibell AD, Michel AD, Barnard EA, and Humphrey PP. Cloning and functional characterisation of the mouse P2X7 receptor. FEBS Lett 439: 26-30, 1998.
4. 7 receptor. J Cell Biol 138: 697-706, 1997.
5. Denlinger LC, Fisette PL, Sommer JA, Watters JJ, Prabhu U, Dubyak GR, Proctor RA, and Bertics PJ. Cutting edge: the nucleotide receptor P2X7 contains multiple protein- and lipid-interaction motifs including a potential binding site for bacterial lipopolysaccharide. J Immunol 167: 1871-1876, 2001.
6. Denlinger LC, Sommer JA, Parker K, Gudipaty L, Fisette PL, Watters JW, Proctor RA, Dubyak GR, and Bertics PJ. Mutation of a dibasic amino acid motif within the C terminus of the P2X7 nucleotide receptor results in trafficking defects and impaired function. J Immunol 171: 1304-1311, 2003.
7. Falzoni S, Chiozzi P, Ferrari D, Buell G, and Di Virgilio F. P2X(7) receptor and polykarion formation. Mol Biol Cell 11: 3169-3176, 2000.
8. Gartland A, Buckley KA, Bowler WB, and Gallagher JA. Blockade of the pore-forming P2X(7) receptor inhibits formation of multinucleated human osteoclasts in vitro. Calcif Tissue Int 73: 361-369, 2003.
9. 7 receptor. J Biol Chem 276: 11135-11142, 2001.
10. 7 receptors. Am J Physiol Cell Physiol 279: C1189-C1197, 2000.
11. 7 nucleotide receptor function in human monocytes by extracellular ions and receptor density. Am J Physiol Cell Physiol 280: C943-C953, 2001.
12. Han X, Sterling H, Chen Y, Saginario C, Brown EJ, Frazier WA, Lindberg FP, and Vignery A. CD47, a ligand for the macrophage fusion receptor, participates in macrophage multinucleation. J Biol Chem 275: 37984-37992, 2000.
13. Hibell AD, Thompson KM, Xing M, Humphrey PP, and Michel AD. Complexities of measuring antagonist potency at P2X(7) receptor orthologs. J Pharmacol Exp Ther 296: 947-957, 2001.
14. Hsu H, Lacey DL, Dunstan CR, Solovyev I, Colombero A, Timms E, Tan HL, Elliott G, Kelley MJ, Sarosi I, Wang L, Xia XZ, Elliott R, Chiu L, Black T, Scully S, Capparelli C, Morony S, Shimamoto G, Bass MB, and Boyle WJ. Tumor necrosis factor receptor family member RANK mediates osteoclast differentiation and activation induced by osteoprotegerin ligand. Proc Natl Acad Sci USA 96: 3540-3545, 1999.
15. Kazazi F, Chang J, Lopez A, Vadas M, and Cunningham AL. Interleukin 4 and human immunodeficiency virus stimulate LFA-1-ICAM-1-mediated aggregation of monocytes and subsequent giant cell formation. J Gen Virol 75: 2795-2802, 1994.
16. 7 nucleotide receptor reveals its regulatory roles in bone formation and resorption. Mol Endocrinol 17: 1356-1367, 2003.
17. Khakh BS, Bao XR, Labarca C, and Lester HA. Neuronal P2X transmitter-gated cation channels change their ion selectivity in seconds. Nat Neurosci 2: 322-330, 1999.
18. 7 receptors to activate NF-kappa B in osteoclasts. J Bone Miner Res 19: 642-651, 2004.
19. Most J, Neumayer HP, and Dierich MP. Cytokine-induced generation of multinucleated giant cells in vitro requires interferon-gamma and expression of LFA-1. Eur J Immunol 20: 1661-1667, 1990.
20. North RA and Surprenant A. Pharmacology of cloned P2X receptors. Annu Rev Pharmacol Toxicol 40: 563-580, 2000.
21. Piper RC, Hess LJ, and James DE. Differential sorting of two glucose transporters expressed in insulin-sensitive cells. Am J Physiol Cell Physiol 260: C570-C580, 1991.
22. Saginario C, Sterling H, Beckers C, Kobayashi R, Solimena M, Ullu E, and Vignery A. MFR, a putative receptor mediating the fusion of macrophages. Mol Cell Biol 18: 6213-6223, 1998.
23. 7 receptor cell surface expression and cytolytic pore formation are regulated by a distal C-terminal region. J Biol Chem 278: 8853-8860, 2003.
24. Steinberg TH, Newman AS, Swanson JA, and Silverstein SC. ATP4-permeabilizes the plasma membrane of mouse macrophages to fluorescent dyes. J Biol Chem 262: 8884-8888, 1987.
25. Sterling H, Saginario C, and Vignery A. CD44 occupancy prevents macrophage multinucleation. J Cell Biol 143: 837-847, 1998.
26. Surprenant A, Rassendren F, Kawashima E, North RA, and Buell G. The cytolytic P2Z receptor for extracellular ATP identified as a P2X receptor (P2X7). Science 272: 735-738, 1996.
27. Takeda Y, Tachibana I, Miyado K, Kobayashi M, Miyazaki T, Funakoshi T, Kimura H, Yamane H, Saito Y, Goto H, Yoneda T, Yoshida M, Kumagai T, Osaki T, Hayashi S, Kawase I, and Mekada E. Tetraspanins CD9 and CD81 function to prevent the fusion of mononuclear phagocytes. J Cell Biol 161: 945-956, 2003.
28. Vignery A. Osteoclasts and giant cells: macrophage-macrophage fusion mechanism. Int J Exp Pathol 81: 291-304, 2000.
29. Virginio C, MacKenzie A, Rassendren FA, North RA, and Surprenant A. Pore dilation of neuronal P2X receptor channels. Nat Neurosci 2: 315-321, 1999.
30. Wiley JS, Dao-Ung LP, Li C, Shemon AN, Gu BJ, Smart ML, Fuller SJ, Barden JA, Petrou S, and Sluyter R. An Ile-568 to Asn polymorphism prevents normal trafficking and function of the human P2X7 receptor. J Biol Chem 278: 17108-17113, 2003.
31. Zambon A, Bronte V, Di Virgilio F, Hanau S, Steinberg TH, Collavo D, and Zanovello P. Role of extracellular ATP in cell-mediated cytotoxicity: a study with ATP-sensitive and ATP-resistant macrophages. Cell Immunol 156: 458-467, 1994.